+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Breast Cancer Screening Market - Global Forecast 2026-2032- Product Image
Breast Cancer Screening Market - Global Forecast 2026-2032- Product Image
Sale

Breast Cancer Screening Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011427
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Breast Cancer Screening Market is projected to reach USD 6.09 Billion in 2026. It is expected to continue growing at a CAGR of 8.00%, reaching USD 9.75 Billion by 2032.

Breast Cancer Screening: Executive Overview

Breast cancer screening combines population-based and risk-adapted approaches intended to detect disease before symptoms appear. Core modalities include mammography, digital breast tomosynthesis, ultrasound, magnetic resonance imaging, and clinical or self-awareness pathways. Outcomes depend on eligibility guidance, participation, diagnostic follow-up, workforce capacity, equipment availability, and equitable access. Screening policy is increasingly shifting from uniform delivery toward approaches that account for age, breast density, inherited risk, prior findings, and individual preferences.

How Screening Systems Are Being Transformed

Screening systems are being reshaped by digital imaging, organized invitation and recall programs, mobile services, risk-stratified pathways, and stronger links between screening and diagnostic care. Digital records and referral coordination can reduce delays between an abnormal screen and definitive assessment, while quality assurance frameworks support consistent image acquisition and interpretation. Persistent challenges include false-positive results, overdiagnosis, uneven participation, limited specialist capacity, and access barriers affecting rural, lower-income, and underserved populations.

Artificial Intelligence Across the Screening Pathway

Artificial intelligence is being evaluated for image triage, lesion detection, workflow prioritization, quality control, risk assessment, and decision support. Its practical value depends on representative training data, independent validation, calibrated performance across modalities and demographic groups, and clear clinician accountability. AI may help manage workload and standardize review, but it does not remove the need for human oversight, transparent communication, cybersecurity, privacy safeguards, and monitoring for bias or performance drift after deployment.

Regional Differences in Breast Cancer Screening

North America generally benefits from established imaging infrastructure and organized quality systems, while debates continue over starting ages, screening intervals, density notification, and supplemental imaging. Europe has broad public-health programs but substantial variation in invitation models, participation, and diagnostic capacity. Asia-Pacific combines advanced screening networks in some economies with major rural and affordability gaps in others. Latin America faces uneven access to mammography, follow-up, and pathology services. The Middle East is developing screening capacity amid differences in public awareness, workforce distribution, and national policy. Africa continues to face limited equipment, specialist shortages, late presentation, and the need for locally appropriate pathways that connect awareness, clinical assessment, imaging, and treatment.

Group-Level Priorities Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members are balancing rapid urbanization and expanding diagnostic services with access gaps across islands, rural areas, and income groups. BRICS countries show wide variation in screening infrastructure, public coverage, and referral continuity, making adaptable national and subnational models important. The European Union emphasizes organized programs, quality assurance, cross-border learning, and equity despite differences among health systems. G7 countries are focusing on evidence-based interval and modality choices, workforce productivity, and responsible digital innovation. GCC members are strengthening prevention and screening capacity while addressing participation and culturally appropriate engagement. NATO members span diverse health systems, so shared priorities include resilience, supply continuity, interoperable data, and access for mobile or underserved populations.

Country-Level Screening Considerations

Australia, Canada, France, Germany, Italy, Japan, Spain, the United Kingdom, and the United States have mature screening capabilities, but continue to address participation, interval design, dense breasts, workforce pressure, and timely diagnostic resolution. Brazil, China, India, Mexico, Russia, and South Korea differ substantially in national organization, regional access, equipment distribution, and integration between screening and treatment. Across all fifteen countries, effective improvement depends on clear eligibility guidance, reliable invitation and recall systems, high-quality imaging, rapid follow-up, transparent performance monitoring, and targeted outreach to populations that are less likely to participate or face longer diagnostic journeys.

Actions for Leaders Improving Screening Performance

Industry leaders should align programs with current national guidance and local disease patterns rather than applying a single universal model. Priorities include investing in quality assurance, mobile and community-linked services, workforce training, interoperable referral systems, and navigation for patients with abnormal findings. AI adoption should proceed through staged validation, subgroup testing, human-in-the-loop governance, and post-deployment auditing. Leaders should also measure participation, recall, diagnostic completion, time to resolution, patient experience, and equity by geography and demographic group. Partnerships with public-health agencies, clinicians, patient organizations, and community leaders can improve trust and reduce avoidable access barriers.

Methodology for the Executive Summary

This executive summary uses the supplied market definition, “Breast Cancer Screening,” and synthesizes verified, generalizable evidence about screening modalities, delivery models, implementation barriers, regional health-system differences, and responsible technology adoption. The analysis is structured around the requested regions, groups, and countries. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific claims. Interpretations are framed as system-level insights and should be checked against current national guidelines, regulatory decisions, and program performance data before operational use.

Building More Equitable and Effective Screening Pathways

Breast cancer screening is moving toward coordinated, risk-aware, digitally supported care, but technology alone will not resolve gaps in participation or follow-up. The strongest systems will combine evidence-based policy, dependable imaging quality, accessible services, prompt diagnostic resolution, trained professionals, and transparent outcome monitoring. Regional and country differences require adaptable implementation, while AI should be introduced cautiously with safeguards for accuracy, equity, privacy, and accountability. Sustained progress will depend on treating screening as a connected pathway rather than an isolated imaging event.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Breast Cancer Screening Market, by Screening Type
7.1. Introduction
7.2. Mammography Screening
7.2.1. Digital Mammography
7.2.2. 2D Mammography
7.2.3. 3D Mammography (Digital Breast Tomosynthesis)
7.3. Breast MRI Screening
7.4. Breast Ultrasound Screening
7.4.1. Handheld Ultrasound
7.4.2. Automated Breast Ultrasound (ABUS)
7.5. Clinical Breast Examination (CBE)
7.6. Thermography Screening
7.7. Molecular Breast Imaging (MBI)
8. Breast Cancer Screening Market, by End User
8.1. Introduction
8.2. Ambulatory Care Centers
8.3. Clinics
8.3.1. Primary Care Clinics
8.3.2. Specialty Clinics
8.4. Diagnostic Centers
8.4.1. Chain Centers
8.4.2. Independent Centers
8.5. Hospitals
9. Breast Cancer Screening Market, by Age Group
9.1. Introduction
9.2. Below 30 Years
9.3. 30-65 Years
9.4. Above 65 Years
10. Breast Cancer Screening Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Breast Cancer Screening Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Breast Cancer Screening Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. AstraZeneca plc
14.2. Bayer AG
14.3. Becton, Dickinson and Company
14.4. Carestream Health, Inc.
14.5. Danaher Corporation
14.6. Exact Sciences Corporation
14.7. F. Hoffmann-La Roche Ltd
14.8. Fujifilm Holdings Corporation
14.9. GE HealthCare Technologies Inc.
14.10. GlaxoSmithKline plc
14.11. Hologic, Inc.
14.12. Koning Health
14.13. Koninklijke Philips N.V.
14.14. Myriad Genetics, Inc.
14.15. NanoString Technologies, Inc.
14.16. NIRAMAI Health Analytix Private Limited
14.17. Novartis AG
14.18. Oncocyte Corporation
14.19. OncoStem Diagnostics Pvt. Ltd
14.20. Pfizer Inc.
14.21. Prelude Corporation
14.22. Quest Diagnostics Incorporated
14.23. Siemens Healthineers AG
14.24. Syantra Inc.
14.25. Vayyar Imaging, Ltd.
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Breast Cancer Screening Market, Years Considered for the Study
FIGURE 2. Global Breast Cancer Screening Market, Research Design
FIGURE 3. Global Breast Cancer Screening Market, Research Framework
FIGURE 4. Global Breast Cancer Screening Market, Data Triangulation
FIGURE 5. Global Breast Cancer Screening Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Breast Cancer Screening Market Size, by Screening Type, 2025 vs 2032 (%)
FIGURE 7. Global Breast Cancer Screening Market Size, by Screening Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Breast Cancer Screening Market Size, by End User, 2025 vs 2032 (%)
FIGURE 9. Global Breast Cancer Screening Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Breast Cancer Screening Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 11. Global Breast Cancer Screening Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Breast Cancer Screening Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Breast Cancer Screening Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Breast Cancer Screening Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Breast Cancer Screening Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Breast Cancer Screening Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Breast Cancer Screening Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Breast Cancer Screening Market Segmentation & Coverage
TABLE 2. Global Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 3. Global Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 4. Global Mammography Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Mammography Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Mammography Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Digital Mammography Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Digital Mammography Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Digital Mammography Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global 2D Mammography Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global 2D Mammography Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global 2D Mammography Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global 3D Mammography (Digital Breast Tomosynthesis) Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global 3D Mammography (Digital Breast Tomosynthesis) Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global 3D Mammography (Digital Breast Tomosynthesis) Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Breast MRI Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Breast MRI Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Breast MRI Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Breast Ultrasound Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Breast Ultrasound Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Breast Ultrasound Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Handheld Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Handheld Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Handheld Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Automated Breast Ultrasound (ABUS) Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Automated Breast Ultrasound (ABUS) Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Automated Breast Ultrasound (ABUS) Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Clinical Breast Examination (CBE) Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Clinical Breast Examination (CBE) Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Clinical Breast Examination (CBE) Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Thermography Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Thermography Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Thermography Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Molecular Breast Imaging (MBI) Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Molecular Breast Imaging (MBI) Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Molecular Breast Imaging (MBI) Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 38. Global Ambulatory Care Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Ambulatory Care Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Ambulatory Care Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Primary Care Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Primary Care Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Primary Care Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Chain Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Chain Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Chain Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Independent Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Independent Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Independent Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 63. Global Below 30 Years Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Below 30 Years Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Below 30 Years Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global 30-65 Years Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global 30-65 Years Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global 30-65 Years Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Above 65 Years Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Above 65 Years Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Above 65 Years Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Breast Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Breast Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 81. North America Breast Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. North America Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 83. North America Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 84. North America Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 85. North America Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. North America Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 87. North America Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 88. North America Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 89. Latin America Breast Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Latin America Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 91. Latin America Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 92. Latin America Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 93. Latin America Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Latin America Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 95. Latin America Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 96. Latin America Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 97. Europe Breast Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Europe Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 99. Europe Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 100. Europe Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 101. Europe Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. Europe Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 103. Europe Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 104. Europe Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 105. Middle East Breast Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Middle East Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 107. Middle East Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 108. Middle East Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 109. Middle East Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. Middle East Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 111. Middle East Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 112. Middle East Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 113. Africa Breast Cancer Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Africa Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 115. Africa Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 116. Africa Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 117. Africa Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. Africa Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 119. Africa Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 120. Africa Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 121. Global Breast Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. ASEAN Breast Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. ASEAN Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 124. ASEAN Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 125. ASEAN Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 126. ASEAN Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. ASEAN Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 128. ASEAN Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 129. ASEAN Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 130. GCC Breast Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. GCC Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 132. GCC Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 133. GCC Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 134. GCC Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. GCC Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 136. GCC Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 137. GCC Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 138. European Union Breast Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. European Union Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 140. European Union Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 141. European Union Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 142. European Union Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. European Union Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 144. European Union Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 145. European Union Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 146. BRICS Breast Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. BRICS Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 148. BRICS Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 149. BRICS Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 150. BRICS Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. BRICS Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 152. BRICS Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 153. BRICS Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 154. G7 Breast Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. G7 Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 156. G7 Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 157. G7 Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 158. G7 Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. G7 Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 160. G7 Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 161. G7 Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 162. NATO Breast Cancer Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. NATO Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 164. NATO Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 165. NATO Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 166. NATO Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. NATO Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 168. NATO Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 169. NATO Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 170. Global Breast Cancer Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. United States Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 172. United States Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 173. United States Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 174. United States Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 175. United States Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. United States Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 177. United States Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 178. United States Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 179. Canada Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 180. Canada Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 181. Canada Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 182. Canada Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 183. Canada Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. Canada Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 185. Canada Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 186. Canada Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 187. Mexico Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 188. Mexico Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 189. Mexico Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 190. Mexico Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 191. Mexico Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Mexico Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 193. Mexico Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 194. Mexico Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 195. Brazil Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 196. Brazil Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 197. Brazil Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 198. Brazil Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 199. Brazil Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Brazil Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 201. Brazil Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 202. Brazil Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 203. United Kingdom Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 204. United Kingdom Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 205. United Kingdom Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 206. United Kingdom Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 207. United Kingdom Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. United Kingdom Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 209. United Kingdom Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 210. United Kingdom Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 211. Germany Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 212. Germany Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 213. Germany Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 214. Germany Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 215. Germany Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Germany Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 217. Germany Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 218. Germany Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 219. France Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 220. France Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 221. France Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 222. France Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 223. France Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. France Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 225. France Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 226. France Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 227. Russia Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 228. Russia Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 229. Russia Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 230. Russia Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 231. Russia Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. Russia Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 233. Russia Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 234. Russia Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 235. Italy Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 236. Italy Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 237. Italy Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 238. Italy Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 239. Italy Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. Italy Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 241. Italy Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 242. Italy Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 243. Spain Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 244. Spain Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 245. Spain Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 246. Spain Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 247. Spain Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. Spain Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 249. Spain Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 250. Spain Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 251. China Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 252. China Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 253. China Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 254. China Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 255. China Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. China Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 257. China Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 258. China Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 259. India Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 260. India Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 261. India Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 262. India Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 263. India Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 264. India Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 265. India Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 266. India Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 267. Japan Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 268. Japan Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 269. Japan Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 270. Japan Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 271. Japan Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Japan Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 273. Japan Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 274. Japan Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 275. Australia Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 276. Australia Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 277. Australia Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 278. Australia Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 279. Australia Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 280. Australia Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 281. Australia Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 282. Australia Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 283. South Korea Breast Cancer Screening Market Size, 2017-2032 (USD Million)
TABLE 284. South Korea Breast Cancer Screening Market Size, by Screening Type, 2017-2032 (USD Million)
TABLE 285. South Korea Breast Cancer Screening Market Size, by Mammography Screening, 2017-2032 (USD Million)
TABLE 286. South Korea Breast Cancer Screening Market Size, by Breast Ultrasound Screening, 2017-2032 (USD Million)
TABLE 287. South Korea Breast Cancer Screening Market Size, by End User, 2017-2032 (USD Million)
TABLE 288. South Korea Breast Cancer Screening Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 289. South Korea Breast Cancer Screening Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 290. South Korea Breast Cancer Screening Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 291. Global Breast Cancer Screening Market Share, by Key Player, 2025
TABLE 292. Global Breast Cancer Screening Market, Key Experts

Companies Mentioned

  • AstraZeneca plc
  • Bayer AG
  • Becton, Dickinson and Company
  • Carestream Health, Inc.
  • Danaher Corporation
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • GlaxoSmithKline plc
  • Hologic, Inc.
  • Koning Health
  • Koninklijke Philips N.V.
  • Myriad Genetics, Inc.
  • NanoString Technologies, Inc.
  • NIRAMAI Health Analytix Private Limited
  • Novartis AG
  • Oncocyte Corporation
  • OncoStem Diagnostics Pvt. Ltd
  • Pfizer Inc.
  • Prelude Corporation
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • Syantra Inc.
  • Vayyar Imaging, Ltd.

Related Topics

Related Reports

Computer-aided Detection for Breast Cancer Screening Market - Global Forecast 2026-2032 - Product Image

Computer-aided Detection for Breast Cancer Screening Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Breast Cancer Screening Device Market - Global Forecast 2026-2032 - Product Image

Breast Cancer Screening Device Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Breast Cancer Diagnostics - Global Strategic Business Report - Product Image

Breast Cancer Diagnostics - Global Strategic Business Report

  • Report
  • 467 Pages
  • Global
From
Breast Cancer Screening and Diagnostics Market - A Global and Regional Analysis: Focus on Product, Application, End User, Regional, and Country-Level Analysis - Analysis and Forecast, 2026-2036 - Product Image

Breast Cancer Screening and Diagnostics Market - A Global and Regional Analysis: Focus on Product, Application, End User, Regional, and Country-Level Analysis - Analysis and Forecast, 2026-2036

  • Report
  • 121 Pages
  • Global
From
Breast Cancer Core Needle Biopsy - Global Strategic Business Report - Product Image

Breast Cancer Core Needle Biopsy - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From

About the Breast Cancer Screening Market

The Breast Cancer Screening market is a key component of Women's Health. It is a preventative measure that helps to detect breast cancer in its early stages, when it is most treatable. Screening typically involves mammography, which is an X-ray imaging test that can detect changes in the breast tissue. Other screening methods include clinical breast exams, breast ultrasounds, and MRI scans. The Breast Cancer Screening market is a growing industry, with many companies offering services to women. These companies provide a range of services, from mammography to MRI scans, to help women detect breast cancer early. Companies in the Breast Cancer Screening market include Breastlink, Breast Cancer Diagnostics, and Breast Health Solutions. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.